Search research articles
Contact Us
Filters
Showing results (101-110 of 108) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 108 results.
Cancer Cell
|
November 12, 2024
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
Robert L Bowman, Andrew J Dunbar, Tanmay Mishra, et al.
Cancer Discovery
|
January 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms
Andrew J Dunbar, Robert L Bowman, Young C Park, et al.
American Journal of Hematology
|
October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Maximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Haematologica
|
March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
Melissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
Blood
|
December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis
Joseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Nature Communications
|
October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
Ryan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Leukemia
|
June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D Khoury, Eric Solary, Oussama Abla, et al.
Leukemia
|
June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 108) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 108 results.
Cancer Cell
|
November 12, 2024
In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
Robert L Bowman, Andrew J Dunbar, Tanmay Mishra, et al.
Cancer Discovery
|
January 17, 2024
Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms
Andrew J Dunbar, Robert L Bowman, Young C Park, et al.
American Journal of Hematology
|
October 17, 2022
Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia
Maximilian Stahl, Andriy Derkach, Noushin Farnoud, et al.
Haematologica
|
March 7, 2024
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
Melissa Krystel-Whittemore, Kseniya Petrova-Drus, Ryan N Ptashkin, et al.
Blood
|
December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis
Joseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Nature Communications
|
October 29, 2023
Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
Ryan N Ptashkin, Mark D Ewalt, Gowtham Jayakumaran, et al.
Leukemia
|
June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D Khoury, Eric Solary, Oussama Abla, et al.
Leukemia
|
June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, et al.
Page
of 11